HEADER PHOSPHOTRANSFERASE 01-APR-97 1JEM TITLE NMR STRUCTURE OF HISTIDINE PHOSPHORYLATED FORM OF THE PHOSPHOCARRIER TITLE 2 HISTIDINE CONTAINING PROTEIN FROM BACILLUS SUBTILIS, NMR, 25 TITLE 3 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTIDINE CONTAINING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HPR; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SUBTILIS; SOURCE 3 ORGANISM_TAXID: 1423; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: GM-1 KEYWDS HISTIDINE CONTAINING PROTEIN, PHOSPHOHISTIDINE, PTS, KEYWDS 2 PHOSPHOTRANSFERASE EXPDTA SOLUTION NMR NUMMDL 25 AUTHOR B.E.JONES,P.RAJAGOPAL,R.E.KLEVIT REVDAT 3 03-NOV-21 1JEM 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1JEM 1 VERSN REVDAT 1 23-JUL-97 1JEM 0 JRNL AUTH B.E.JONES,P.RAJAGOPAL,R.E.KLEVIT JRNL TITL PHOSPHORYLATION ON HISTIDINE IS ACCOMPANIED BY LOCALIZED JRNL TITL 2 STRUCTURAL CHANGES IN THE PHOSPHOCARRIER PROTEIN, HPR FROM JRNL TITL 3 BACILLUS SUBTILIS. JRNL REF PROTEIN SCI. V. 6 2107 1997 JRNL REFN ISSN 0961-8368 JRNL PMID 9336834 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.RAJAGOPAL,E.B.WAYGOOD,R.E.KLEVIT REMARK 1 TITL STRUCTURAL CONSEQUENCES OF HISTIDINE PHOSPHORYLATION: NMR REMARK 1 TITL 2 CHARACTERIZATION OF THE PHOSPHOHISTIDINE FORM OF REMARK 1 TITL 3 HISTIDINE-CONTAINING PROTEIN FROM BACILLUS SUBTILIS AND REMARK 1 TITL 4 ESCHERICHIA COLI REMARK 1 REF BIOCHEMISTRY V. 33 15271 1994 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.WITTEKIND,P.RAJAGOPAL,B.R.BRANCHINI,J.REIZER, REMARK 1 AUTH 2 M.H.SAIER JUNIOR,R.E.KLEVIT REMARK 1 TITL SOLUTION STRUCTURE OF THE PHOSPHOCARRIER PROTEIN HPR FROM REMARK 1 TITL 2 BACILLUS SUBTILIS BY TWO-DIMENSIONAL NMR SPECTROSCOPY REMARK 1 REF PROTEIN SCI. V. 1 1363 1992 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.WITTEKIND,J.REIZER,R.E.KLEVIT REMARK 1 TITL SEQUENCE-SPECIFIC 1H NMR RESONANCE ASSIGNMENTS OF BACILLUS REMARK 1 TITL 2 SUBTILIS HPR: USE OF SPECTRA OBTAINED FROM MUTANTS TO REMARK 1 TITL 3 RESOLVE SPECTRAL OVERLAP REMARK 1 REF BIOCHEMISTRY V. 29 7191 1990 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.0 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JEM COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174319. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.9 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : 500.13 MHZ REMARK 210 SPECTROMETER MODEL : DMX-500 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 25 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ILE A 14 58.34 -109.52 REMARK 500 1 HIP A 15 -146.96 -85.32 REMARK 500 1 LYS A 45 53.83 -90.92 REMARK 500 1 ALA A 68 -74.14 -80.96 REMARK 500 1 ASP A 69 50.08 -91.78 REMARK 500 2 ILE A 14 77.81 -113.76 REMARK 500 2 HIP A 15 -146.01 -100.01 REMARK 500 2 TYR A 37 74.16 -116.40 REMARK 500 2 ASN A 38 85.18 48.30 REMARK 500 2 THR A 41 75.93 -150.10 REMARK 500 2 LYS A 45 56.10 -90.71 REMARK 500 2 SER A 46 89.87 -150.21 REMARK 500 2 ALA A 68 -89.75 55.88 REMARK 500 3 THR A 9 24.81 -140.24 REMARK 500 3 ILE A 14 79.87 -113.66 REMARK 500 3 HIP A 15 -163.59 -102.12 REMARK 500 3 ASN A 38 85.07 48.13 REMARK 500 3 LYS A 45 48.73 -88.47 REMARK 500 3 ASP A 69 45.86 -104.83 REMARK 500 3 LEU A 86 -50.71 -140.50 REMARK 500 4 HIP A 15 -155.21 -108.37 REMARK 500 4 ALA A 31 -179.78 -63.20 REMARK 500 4 LYS A 45 49.98 -87.67 REMARK 500 4 ALA A 68 -73.05 -81.90 REMARK 500 4 ASP A 69 51.90 -90.31 REMARK 500 5 HIP A 15 -152.72 -100.11 REMARK 500 5 TYR A 37 115.27 -160.38 REMARK 500 5 LYS A 45 56.57 -90.28 REMARK 500 5 SER A 46 86.55 -150.37 REMARK 500 5 ASP A 69 42.41 -96.28 REMARK 500 6 ILE A 14 59.56 -114.69 REMARK 500 6 HIP A 15 -142.78 -84.76 REMARK 500 6 LYS A 45 48.26 -88.55 REMARK 500 6 ASP A 69 46.53 -93.77 REMARK 500 7 HIP A 15 -159.71 -106.17 REMARK 500 7 ASP A 32 76.03 -102.75 REMARK 500 7 TYR A 37 87.54 -155.36 REMARK 500 7 LEU A 53 -72.98 -64.31 REMARK 500 7 ASP A 69 52.65 -104.44 REMARK 500 8 HIP A 15 -157.16 -101.67 REMARK 500 8 TYR A 37 72.32 -106.16 REMARK 500 8 ASN A 38 85.49 48.45 REMARK 500 8 LYS A 45 49.14 -86.92 REMARK 500 8 ALA A 68 -71.23 -80.58 REMARK 500 9 HIP A 15 -143.26 -104.37 REMARK 500 9 TYR A 37 115.82 -160.28 REMARK 500 9 LEU A 53 -76.04 -69.15 REMARK 500 9 ASP A 69 42.07 -96.08 REMARK 500 10 HIP A 15 -156.95 -107.48 REMARK 500 10 LYS A 45 48.93 -87.63 REMARK 500 REMARK 500 THIS ENTRY HAS 131 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG A 17 0.32 SIDE CHAIN REMARK 500 2 ARG A 17 0.30 SIDE CHAIN REMARK 500 3 ARG A 17 0.29 SIDE CHAIN REMARK 500 4 ARG A 17 0.32 SIDE CHAIN REMARK 500 5 ARG A 17 0.25 SIDE CHAIN REMARK 500 6 ARG A 17 0.27 SIDE CHAIN REMARK 500 7 ARG A 17 0.29 SIDE CHAIN REMARK 500 8 ARG A 17 0.31 SIDE CHAIN REMARK 500 9 ARG A 17 0.31 SIDE CHAIN REMARK 500 10 ARG A 17 0.31 SIDE CHAIN REMARK 500 11 ARG A 17 0.31 SIDE CHAIN REMARK 500 12 ARG A 17 0.29 SIDE CHAIN REMARK 500 13 ARG A 17 0.23 SIDE CHAIN REMARK 500 14 ARG A 17 0.31 SIDE CHAIN REMARK 500 15 ARG A 17 0.29 SIDE CHAIN REMARK 500 16 ARG A 17 0.32 SIDE CHAIN REMARK 500 17 ARG A 17 0.31 SIDE CHAIN REMARK 500 18 ARG A 17 0.30 SIDE CHAIN REMARK 500 19 ARG A 17 0.26 SIDE CHAIN REMARK 500 20 ARG A 17 0.24 SIDE CHAIN REMARK 500 21 ARG A 17 0.32 SIDE CHAIN REMARK 500 22 ARG A 17 0.32 SIDE CHAIN REMARK 500 23 ARG A 17 0.27 SIDE CHAIN REMARK 500 24 ARG A 17 0.30 SIDE CHAIN REMARK 500 25 ARG A 17 0.25 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 1JEM A 2 88 UNP P08877 PTHP_BACSU 1 87 SEQADV 1JEM HIP A 15 UNP P08877 HIS 14 MODIFIED RESIDUE SEQADV 1JEM VAL A 51 UNP P08877 MET 50 ENGINEERED MUTATION SEQRES 1 A 87 ALA GLN LYS THR PHE LYS VAL THR ALA ASP SER GLY ILE SEQRES 2 A 87 HIP ALA ARG PRO ALA THR VAL LEU VAL GLN THR ALA SER SEQRES 3 A 87 LYS TYR ASP ALA ASP VAL ASN LEU GLU TYR ASN GLY LYS SEQRES 4 A 87 THR VAL ASN LEU LYS SER ILE MET GLY VAL VAL SER LEU SEQRES 5 A 87 GLY ILE ALA LYS GLY ALA GLU ILE THR ILE SER ALA SER SEQRES 6 A 87 GLY ALA ASP GLU ASN ASP ALA LEU ASN ALA LEU GLU GLU SEQRES 7 A 87 THR MET LYS SER GLU GLY LEU GLY GLU MODRES 1JEM HIP A 15 HIS ND1-PHOSPHONOHISTIDINE HET HIP A 15 21 HETNAM HIP ND1-PHOSPHONOHISTIDINE FORMUL 1 HIP C6 H11 N3 O5 P 1+ HELIX 1 1 ARG A 17 LYS A 28 1 12 HELIX 2 2 ILE A 47 LEU A 53 1 7 HELIX 3 3 GLU A 70 GLU A 84 1 15 SHEET 1 A 2 GLN A 3 VAL A 8 0 SHEET 2 A 2 ALA A 59 SER A 64 -1 N ILE A 63 O LYS A 4 SHEET 1 B 2 ASN A 34 TYR A 37 0 SHEET 2 B 2 LYS A 40 ASN A 43 -1 N VAL A 42 O LEU A 35 LINK C ILE A 14 N HIP A 15 1555 1555 1.31 LINK C HIP A 15 N ALA A 16 1555 1555 1.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1